Leef Brands (LEEEF) Short term Debt (2024 - 2026)

Leef Brands (LEEEF) posted Short term Debt of $105000.0 for Q1 2026, down 69.12% sequentially from $340000.0 in Q4 2025.

Leef Brands (LEEEF) Short term Debt (2024 - 2026) Analysis & Trends

Leef Brands has reported Short term Debt for 3 years, with the latest figure at $105000.0 in Q1 2026.

Quarterly Short term Debt changed N/A year-over-year to $105000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $105000.0 (changed N/A YoY) and the FY2025 annual result came in at $340000.0, down 32.0% from the prior year.
Short term Debt fell to $105000.0 in Q1 2026 per LEEEF's latest filing, from $340000.0 in the prior quarter.
Over five years, Short term Debt peaked at $500000.0 in Q4 2024 and troughed at $105000.0 in Q1 2026.
A 3-year average of $315000.0 and a median of $340000.0 in 2025 frame the typical range for Short term Debt.
The widest YoY moves for Short term Debt: up 32.0% in 2025, down 32.0% in 2025.
Over 3 years, Short term Debt stood at $500000.0 in 2024, then slumped by 32.0% to $340000.0 in 2025, then tumbled by 69.12% to $105000.0 in 2026.
According to Business Quant data, Short term Debt over the past three periods registered $105000.0, $340000.0, and $500000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn

Download Data